Enfortumab vedotin plus pembrolizumab in metastatic urothelial carcinoma: First results on outcomes and safety in a German multicenter real-world patient cohort (GUARDIANS)

Zschaebitz, Stefanie and Casuscelli, Jozefina and Buettner, Thomas and Darr, Christopher and Volk, Anna-Lisa and Hennig, Martin and Holzwarth, Nina and Zengerling, Friedemann and Dib, Muammar and Schlack, Katrin and Paffenholz, Pia and Heinzelbecker, Julia and Mandal, Subhajit and Wessels, Frederik and Seidl, Daniel and Erne, Eva and Foller, Susan and Hoellein, Alexander and Gruenwald, Viktor and Schnabel, Marco Julius (2025) Enfortumab vedotin plus pembrolizumab in metastatic urothelial carcinoma: First results on outcomes and safety in a German multicenter real-world patient cohort (GUARDIANS). JOURNAL OF CLINICAL ONCOLOGY, 43 (5_SUPP). p. 715. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Urologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 19 Nov 2026 06:30
Last Modified: 19 Nov 2026 06:30
URI: https://pred.uni-regensburg.de/id/eprint/67656

Actions (login required)

View Item View Item